CC BY-NC-ND 4.0 · Asian J Neurosurg 2017; 12(03): 506-513
DOI: 10.4103/1793-5482.185068
ORIGINAL ARTICLE

Skull base bony lesions: Management nuances; a retrospective analysis from a Tertiary Care Centre

Amit Singh
Department of Neurosurgery, SGPGIMS, Lucknow, Uttar Pradesh
,
Arun Srivastava
Department of Neurosurgery, SGPGIMS, Lucknow, Uttar Pradesh
,
Jayesh Sardhara
Department of Neurosurgery, SGPGIMS, Lucknow, Uttar Pradesh
,
Kamlesh Bhaisora
Department of Neurosurgery, SGPGIMS, Lucknow, Uttar Pradesh
,
Kuntal Das
Department of Neurosurgery, SGPGIMS, Lucknow, Uttar Pradesh
,
Anant Mehrotra
Department of Neurosurgery, SGPGIMS, Lucknow, Uttar Pradesh
,
Rabi Sahu
Department of Neurosurgery, SGPGIMS, Lucknow, Uttar Pradesh
,
Awadhesh Jaiswal
Department of Neurosurgery, SGPGIMS, Lucknow, Uttar Pradesh
,
Sanjay Behari
Department of Neurosurgery, SGPGIMS, Lucknow, Uttar Pradesh
› Author Affiliations

Background: Skull base lesions are not uncommon, but their management has been challenging for surgeons. There is large no of bony tumors at the skull base which has not been studied in detail as a group. These tumors are difficult not only because of their location but also due to their variability in the involvement of important local structure. Through this retrospective analysis from a Tertiary Care Centre, we are summarizing the details of skull base bony lesions and its management nuances. Materials and Methods: The histopathologically, radiologically, and surgically proven cases of skull base bony tumors or lesions involving bone were analyzed from the neurosurgery, neuropathology record of our Tertiary Care Institute from January 2009 to January 2014. All available preoperative and postoperative details were noted from their case files. The extent of excision was ascertained from operation records and postoperative magnetic resonance imaging if available. Results: We have surgically managed 41 cases of skull base bony tumors. It includes 11 patients of anterior skull base, 13 middle skull base, and 17 posterior skull base bony tumors. The most common bony tumor was chordoma 15 (36.6%), followed by fibrous dysplasia 5 (12.2%), chondrosarcoma (12.2%), and ewings sarcoma-peripheral primitive neuroectodermal tumor (EWS-pPNET) five cases (12.2%) each. There were more malignant lesions (n = 29, 70.7%) at skull base than benign (n = 12, 29.3%) lesions. The surgical approach employed depended on location of tumor and pathology. Total mortality was 8 (20%) of whom 5 patients were of histological proven EWS-pPNET. Conclusions: Bony skull base lesion consists of wide variety of lesions, and requires multispecialty management. The complex lesions required tailored approaches surgery of these lesions. With the advent of microsurgical and endoscopic techniques, and use of navigation better outcomes are being seen, but these lesions require further study for development of proper management plan.



Publication History

Article published online:
20 September 2022

© 2017. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India